Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Spain
  • Study on the Effect of Prasterone on Genitourinary Syndrome in Postmenopausal Women with a History of Breast Cancer or Undergoing Anti-Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy
  • Study of Fertility Preservation Using Tamoxifen, Follitropin Beta, Cetrorelix and Choriogonadotropin Alfa in Women with Breast Cancer Before Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +6
  • Study of Combined Imaging with Hyperpolarized [1-13C]Pyruvate and Fludeoxyglucose (18F) for Cancer Detection in Patients with Breast Cancer, Neuroendocrine Tumors, Lymphomas, or Sarcomas

    Recruiting

    2 1 1 1
    Denmark
  • Study on Personalized Treatment for Hormone Receptor Positive HER2 Negative Breast Cancer Using Capivasertib, Letrozole, and Bevacizumab for Eligible Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study on Pravastatin for Patients with Severe Radio-Induced Breast Fibrosis After Breast Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Breast Cancer Treatment with Carboplatin for Patients in Neoadjuvant and Metastatic Stages

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Recruiting

    3 1 1 1
    Austria Bulgaria Czechia France Germany Hungary +4